FUTURE OF NEWBORN STEM CELL BANKING: UNLOCKING LIFE-SAVING POTENTIAL FOR FUTURE GENERATIONS
Healthcare Radius
|March 2025
As medical science advances, the promise of stem cell therapy grows stronger. From treating blood disorders to exploring possibilities in regenerative medicine, cord blood banking is emerging as a powerful tool for safeguarding our children's health.
The need to secure a child's future, in health, and otherwise, perhaps remains one of the most unswerving emotions that parents feel throughout their lives. More so, at the very birth of a child, not least in a world which is driven by uncertainty and is ever-evolving. It doesn't come as a surprise then, that parents are now increasingly turning to preservation of the umbilical cord blood of their newborn, a valuable resource, which could offer a life-saving solution in case of a future disease.
Umbilical cord blood, which can be collected and stored after a baby is born, contains lifesaving stem cells that have been used to regenerate healthy blood in over 30,000 transplants worldwide and treat hematological, genetical, immunological disorders and even other life threatening diseases.
But first, it is perhaps important to understand what cord blood derived stem cells are? In essence, cord blood stem cells are the building blocks of the human body. They are naïve or unspecialized which means they have the ability to grow into specialized cells. A stem cell inside an embryo for instance, will eventually give rise to every cell, tissue and organ in the foetus. There are two types of stem cells – Hematopoietic, found in cord blood and bone marrow and Mesenchymal, which can be isolated from umbilical cord tissue and other sources and are also called 'organ forming' cells.Newborn cord blood is valuable because it contains the hematopoietic stem cells, which have the ability to regenerate and treat a range of blood and immune system disorders – those that require stem cell transplants. Certain kinds of hematological disorders like leukemia or lymphoma, aplastic anemia, and many other genetic disorders like thalassemia can be treated with the stem cells extracted from the newborn cord blood.
यह कहानी Healthcare Radius के March 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Healthcare Radius से और कहानियाँ
Healthcare Radius
VENUS REMEDIES GETS DRUG APPROVALS IN VIETNAM
Venus Remedies, a fixed-dosage injectable manufacturer, has secured new marketing authorisations for Methotrexate, Cefuroxime, and Irinotecan in Vietnam.
1 mins
December 2025
Healthcare Radius
A HEALTHIER INDIA IN THE MAKING: LEADERS DECODE THE ROAD FROM 2025 TO 2026
The collective goal is clear and unanimous: to transition from a system that primarily treats sickness to one that actively promotes lifelong health and well-being.
12 mins
December 2025
Healthcare Radius
FROM GENES TO CARE: ADVANCING CLINICAL UNDERSTANDING OF HYPOPHOSPHATASIA
From genes to care, the story of hypophosphatasia reminds us that progress in medicine isn't only about scientific discovery, it's about turning knowledge into healing.
6 mins
December 2025
Healthcare Radius
ALEMBIC PHARMA GETS USFDA NOD FOR DILTIAZEM TABLETS IN THE US
Alembic Pharmaceuticals (Alembic) Aamour announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.
1 min
December 2025
Healthcare Radius
ZYDUS GETS USFDA APPROVAL FOR PROSTATE CANCER INJECTABLE
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial (USRLD: Lupron Injection®, 1 mg/0.2 mL).
1 min
December 2025
Healthcare Radius
SUPERHEALTH LAUNCHES HONEST SECOND OPINION FOR PATIENTS
Superhealth, a zero-wait, commission Superhealth, zerohospital network, announced the launch of \"Honest Second Opinion,\" a service that helps patients make informed decisions about their treatment plans and surgical recommendations.
1 min
December 2025
Healthcare Radius
KOTAK ALTS INVESTS RS 400MN IN MEDIVERSAL
Kotak Alternate Asset Managers (Kotak Alts), through its Kotak Life Science Fund I, which invests in early to growth-stage life sciences and healthcare businesses, has made an investment of Rs 400 million in Mediversal Healthcare.
1 min
December 2025
Healthcare Radius
INVIGA HEALTHCARE FUND ACQUIRES 21% STAKE IN FORUS HEALTH
Inviga Healthcare Fund (IHF), the private equity platform founded by Dr B. S. Ajaikumar of HCG, has acquired a 21 per cent stake in Forus Health, an ophthalmic diagnostics company whose devices have screened over 22 million patients across 75+ countries.
1 min
December 2025
Healthcare Radius
OPTIMISING MATERNITY OPS: REDUCING C-SECTION BURDEN THROUGH EVIDENCE-BASED PROTOCOLS
By building systems that support safety, documentation, and respectful care, institutions can improve outcomes, lower litigation risks, and strengthen quality scores, achieving what healthcare should truly represent: Care Through Trust.”
7 mins
December 2025
Healthcare Radius
MENTAL HEALTH CARE GOES DIGITAL WITH NEW THERAPY PLATFORM
Following the global observance and continuing the commitment to mental well-being, renowned clinical psychologist Kanika Jindal announced the launch of Harmony Therapy World, a holistic digital platform designed to bring emotional healing and psychological support to people everywhere, privately, compassionately, and without barriers.
1 min
December 2025
Listen
Translate
Change font size

